Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 15 studies | 57% ± 18% | |
| microglial cell | 12 studies | 36% ± 13% | |
| endothelial cell | 11 studies | 26% ± 8% | |
| fibroblast | 8 studies | 36% ± 14% | |
| mast cell | 8 studies | 24% ± 7% | |
| adipocyte | 7 studies | 26% ± 6% | |
| endothelial cell of lymphatic vessel | 7 studies | 45% ± 17% | |
| macrophage | 7 studies | 32% ± 7% | |
| smooth muscle cell | 6 studies | 29% ± 9% | |
| myeloid cell | 5 studies | 23% ± 7% | |
| cardiac muscle cell | 5 studies | 50% ± 12% | |
| pericyte | 4 studies | 34% ± 5% | |
| monocyte | 4 studies | 22% ± 6% | |
| epithelial cell | 3 studies | 44% ± 19% | |
| hepatocyte | 3 studies | 37% ± 12% | |
| glutamatergic neuron | 3 studies | 30% ± 5% | |
| alveolar macrophage | 3 studies | 31% ± 9% | |
| ciliated cell | 3 studies | 20% ± 7% | |
| basal cell | 3 studies | 28% ± 15% | |
| goblet cell | 3 studies | 45% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 99% | 2984.76 | 1436 / 1445 | 100% | 16.89 | 183 / 183 |
| pancreas | 99% | 1860.61 | 326 / 328 | 98% | 12.70 | 174 / 178 |
| kidney | 99% | 1414.88 | 88 / 89 | 95% | 8.72 | 859 / 901 |
| uterus | 100% | 1325.79 | 170 / 170 | 92% | 11.70 | 422 / 459 |
| intestine | 93% | 1871.20 | 901 / 966 | 97% | 8.14 | 513 / 527 |
| lung | 94% | 971.26 | 544 / 578 | 94% | 11.42 | 1086 / 1155 |
| skin | 93% | 3601.14 | 1684 / 1809 | 89% | 8.17 | 422 / 472 |
| liver | 99% | 1614.52 | 223 / 226 | 82% | 7.77 | 334 / 406 |
| stomach | 84% | 714.30 | 302 / 359 | 96% | 7.79 | 275 / 286 |
| breast | 99% | 1661.25 | 456 / 459 | 78% | 4.63 | 871 / 1118 |
| adrenal gland | 100% | 5820.22 | 258 / 258 | 66% | 4.53 | 152 / 230 |
| bladder | 76% | 756.62 | 16 / 21 | 86% | 6.47 | 434 / 504 |
| ovary | 100% | 4011.43 | 180 / 180 | 44% | 1.91 | 189 / 430 |
| thymus | 96% | 1013.37 | 626 / 653 | 47% | 2.17 | 287 / 605 |
| prostate | 86% | 830.33 | 211 / 245 | 35% | 1.21 | 176 / 502 |
| brain | 61% | 866.15 | 1616 / 2642 | 53% | 2.31 | 377 / 705 |
| spleen | 100% | 2172.92 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 99% | 1672.71 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 1904.33 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 18.02 | 44 / 45 |
| heart | 97% | 2222.26 | 837 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 3.44 | 21 / 29 |
| peripheral blood | 48% | 498.22 | 442 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 39% | 1.39 | 31 / 80 |
| muscle | 6% | 35.64 | 50 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007265 | Biological process | Ras protein signal transduction |
| GO_0060627 | Biological process | regulation of vesicle-mediated transport |
| GO_0031670 | Biological process | cellular response to nutrient |
| GO_0006935 | Biological process | chemotaxis |
| GO_0032534 | Biological process | regulation of microvillus assembly |
| GO_0007264 | Biological process | small GTPase-mediated signal transduction |
| GO_0098693 | Biological process | regulation of synaptic vesicle cycle |
| GO_0045727 | Biological process | positive regulation of translation |
| GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
| GO_0009395 | Biological process | phospholipid catabolic process |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0031902 | Cellular component | late endosome membrane |
| GO_0035579 | Cellular component | specific granule membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0098981 | Cellular component | cholinergic synapse |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0070821 | Cellular component | tertiary granule membrane |
| GO_0098590 | Cellular component | plasma membrane region |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005768 | Cellular component | endosome |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0070290 | Molecular function | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| GO_0004630 | Molecular function | phospholipase D activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PLD1 |
| Protein name | Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1) Phospholipase D1 phospholipase D (EC 3.1.4.4) |
| Synonyms | |
| Description | FUNCTION: Function as phospholipase selective for phosphatidylcholine . Implicated as a critical step in numerous cellular pathways, including signal transduction, membrane trafficking, and the regulation of mitosis. May be involved in the regulation of perinuclear intravesicular membrane traffic (By similarity). . |
| Accessions | Q13393 ENST00000351298.9 [Q13393-1] C9IY79 ENST00000440204.5 H7C0L3 ENST00000418087.1 ENST00000446289.1 ENST00000627725.1 ENST00000356327.9 [Q13393-2] F8WBV7 |